Longterm outcomes of rheumatoid arthritis patients with severe osteoporosis treated with either Teriparatide or antiresorptive treatment – an observational study

• Barbara Hauser,
• Kathryn Berg,
• Justine Lambert,
• Stuart H. Ralston

Affiliations

Barbara Hauser

Nhs Lothian, Rheumatology, Edinburgh, United Kingdom; Rheumatology and Bone Disease Unit- Centre for Genomic and Experimental Medicine- MRC institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom; Corresponding author.

Kathryn Berg

Rheumatology and Bone Disease Unit- Centre for Genomic and Experimental Medicine- MRC institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom

Justine Lambert

Rheumatology and Bone Disease Unit- Centre for Genomic and Experimental Medicine- MRC institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom

Stuart H. Ralston

Nhs Lothian, Rheumatology, Edinburgh, United Kingdom; Rheumatology and Bone Disease Unit- Centre for Genomic and Experimental Medicine- MRC institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom